Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Herpes simplex virus type 2 (HSV-2) encodes several envelope glycoproteins that are critical for viral entry, cell-to-cell spread, immune evasion, and pathogenesis. The most studied glycoproteins include gB (glycoprotein B), gD (glycoprotein D), gG (glycoprotein G), and others. Each plays a distinct role in the viral life cycle and presents a target for therapeutic intervention.
Inhibition of viral DNA polymerase; disruption of viral entry/fusion
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Herpes Simplex Virus Type 2 Glycoproteins (HSV-2 Glycoproteins).